NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3,477.06% | -69.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3,477.06% | -69.03% | |||
| Cost of Revenue | 4,619.05% | -73.08% | |||
| Gross Profit | 2,761.19% | -65.64% | |||
| SG&A Expenses | 330.11% | -61.55% | |||
| Depreciation & Amortization | -2.40% | -8.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 288.60% | -55.74% | |||
| Operating Income | -217.91% | 55.32% | |||
| Income Before Tax | -211.05% | 48.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -212.17% | 48.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -212.17% | 48.70% | |||
| EBIT | -217.91% | 55.32% | |||
| EBITDA | -281.78% | 61.54% | |||
| EPS Basic | -212.50% | 51.52% | |||
| Normalized Basic EPS | -100.00% | 24.39% | |||
| EPS Diluted | -212.50% | 51.52% | |||
| Normalized Diluted EPS | -100.00% | 24.39% | |||
| Average Basic Shares Outstanding | 0.67% | 5.31% | |||
| Average Diluted Shares Outstanding | 0.67% | 5.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||